These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21113375)

  • 1. Upstream therapy in patients with early atrial fibrillation: The relevance of the Routine versus Aggressive upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) study.
    Van Gelder IC; Smit MD; Alings M; Crijns HJ
    Neth Heart J; 2010 Nov; 18(11):522-3. PubMed ID: 21113375
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study.
    Alings M; Smit MD; Moes ML; Crijns HJ; Tijssen JG; Brügemann J; Hillege HL; Lane DA; Lip GY; Smeets JR; Tieleman RG; Tukkie R; Willems FF; Vermond RA; Van Veldhuisen DJ; Van Gelder IC
    Neth Heart J; 2013 Jul; 21(7-8):354-63. PubMed ID: 23700039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial.
    Nguyen BO; Crijns HJGM; Tijssen JGP; Geelhoed B; Hobbelt AH; Hemels MEW; Mol WJM; Weijs B; Alings M; Smit MD; Tieleman RG; Tukkie R; Van Veldhuisen DJ; Van Gelder IC; Rienstra M;
    Europace; 2022 Jul; 24(6):910-920. PubMed ID: 34791160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study.
    De With RR; Rienstra M; Smit MD; Weijs B; Zwartkruis VW; Hobbelt AH; Alings M; Tijssen JGP; Brügemann J; Geelhoed B; Hillege HL; Tukkie R; Hemels ME; Tieleman RG; Ranchor AV; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC
    Europace; 2019 Apr; 21(4):563-571. PubMed ID: 30629160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the rhythm control treatment strategy versus the rate control strategy in patients with permanent or long-standing persistent atrial fibrillation and heart failure treated with cardiac resynchronization therapy - a pilot study of Cardiac Resynchronization in Atrial Fibrillation Trial (Pilot-CRAfT): study protocol for a randomized controlled trial.
    Ciszewski J; Maciag A; Kowalik I; Syska P; Lewandowski M; Farkowski MM; Borowiec A; Chwyczko T; Pytkowski M; Szwed H; Sterlinski M
    Trials; 2014 Oct; 15():386. PubMed ID: 25281275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial fibrillation and heart failure: cause or effect?].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2002 Sep; 3(9):899-907. PubMed ID: 12407857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhythm control versus rate control for atrial fibrillation and heart failure.
    Roy D; Talajic M; Nattel S; Wyse DG; Dorian P; Lee KL; Bourassa MG; Arnold JM; Buxton AE; Camm AJ; Connolly SJ; Dubuc M; Ducharme A; Guerra PG; Hohnloser SH; Lambert J; Le Heuzey JY; O'Hara G; Pedersen OD; Rouleau JL; Singh BN; Stevenson LW; Stevenson WG; Thibault B; Waldo AL;
    N Engl J Med; 2008 Jun; 358(25):2667-77. PubMed ID: 18565859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.
    Middlekauff HR; Stevenson WG; Stevenson LW
    Circulation; 1991 Jul; 84(1):40-8. PubMed ID: 2060110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.
    Rillig A; Magnussen C; Ozga AK; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Kuck KH; Ng A; Szumowski L; van Gelder I; Wegscheider K; Kirchhof P
    Circulation; 2021 Sep; 144(11):845-858. PubMed ID: 34328366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream therapy of atrial fibrillation.
    Smit MD; Van Gelder IC
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):763-78. PubMed ID: 19589113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation - Data from the RACE 3 study.
    Nguyen BO; Wijtvliet EPJP; Hobbelt AH; De Vries SIM; Smit MD; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Rienstra M;
    Int J Cardiol Heart Vasc; 2020 Dec; 31():100673. PubMed ID: 33251324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and heart failure comorbidity.
    Schuchert A
    Minerva Cardioangiol; 2005 Aug; 53(4):299-311. PubMed ID: 16177674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study.
    Hagens VE; Van Veldhuisen DJ; Kamp O; Rienstra M; Bosker HA; Veeger NJ; Tijssen JG; Crijns HJ; Van Gelder IC;
    Heart Rhythm; 2005 Jan; 2(1):19-24. PubMed ID: 15851259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    Kirchhof P; Camm AJ; Goette A; Brandes A; Eckardt L; Elvan A; Fetsch T; van Gelder IC; Haase D; Haegeli LM; Hamann F; Heidbüchel H; Hindricks G; Kautzner J; Kuck KH; Mont L; Ng GA; Rekosz J; Schoen N; Schotten U; Suling A; Taggeselle J; Themistoclakis S; Vettorazzi E; Vardas P; Wegscheider K; Willems S; Crijns HJGM; Breithardt G;
    N Engl J Med; 2020 Oct; 383(14):1305-1316. PubMed ID: 32865375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial.
    Jensen M; Suling A; Metzner A; Schnabel RB; Borof K; Goette A; Haeusler KG; Zapf A; Wegscheider K; Fabritz L; Diener HC; Thomalla G; Kirchhof P
    Lancet Neurol; 2023 Jan; 22(1):45-54. PubMed ID: 36517170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
    Carson PE; Johnson GR; Dunkman WB; Fletcher RD; Farrell L; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI102-10. PubMed ID: 8500233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhythm Control of Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction.
    Burkman G; Naccarelli GV
    Curr Cardiol Rep; 2020 Jul; 22(9):83. PubMed ID: 32647927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation in patients with heart failure: pharmacologic options.
    Matalka MS; Deedwania PC
    Congest Heart Fail; 2001; 7(1):22-29. PubMed ID: 11828132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.